Big Update from CGN in their December Newsletter! Dear all,
We wanted to get in touch and let you know about some great publicity Cognetivity has received in the past few weeks.
In November, Chinese news channel CGTN (China Global Television Network) broadcast a ten-minute report on Cognetivity on RAZOR, its dedicated weekly show on the cutting edge of science and technology. The episode profiles our technology and highlights the enormous global health and economic burden of dementia, centering on the critical problem of late diagnosis; it’s available online and our feature begins ten minutes in. We’re thrilled to see our work showcased to Chinese viewers, who represent major potential users of our products in the future, by a media outlet whose international reach takes in hundreds of millions of people. Over 150 million Chinese citizens are 65+ years old, a figure set to rise to 330 million by 2050.
Furthermore, Cognetivity has been included in Healthcare Weekly’s list of the ‘Best Healthcare Startups to Watch in 2020’ (link: https://healthcareweekly.com/best-healthcare-startups-to-watch-for-in-2019/ ). The digital magazine reviewed more than 200 healthcare startups around the world and included Cognetivity as one of only five UK-based startups on its final list, alongside the subscription health service Babylon (whose valuation after a recent raise of $550 million reportedly exceeded $2 billion).
This coverage is certainly a positive way for us to begin closing out the year - but we remain focussed on the imminent announcement of our successful CE marking certification. Watch this space!
Best wishes,
The team at Cognetivity
.
.
.
.
It's happening people!! CE Mark is coming any day. and with that comes a strong influx of potential revenues. CGN already has a well built network with NHS and UK government. The NHS & UK Gov helped facilitate the required trials and they believe in this product and company... after all the UK Government did just gift them $1.3mm in grant money a couple months ago. CGN will be able to save the NHS alot of money, so this is a no-brainer for them!
I'm bullish and continue to accumulate shares for the numerous catalysts CGN have coming up in 2019 and into 2020.